NASDAQ Stock Exchange News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 1314,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "d31a3d06-1bfd-428b-9ede-3123a80729c7",
"title": "Former exec Baglino sells Tesla shares worth $181.5 million, SEC filing shows By Reuters",
"description": "Former exec Baglino sells Tesla shares worth $181.5 million, SEC filing shows",
"keywords": "",
"snippet": "(Reuters) - Former Tesla (NASDAQ: ) executive Drew Baglino has sold shares worth around $181.5 million in the world's top EV maker, according to a SEC filing on...",
"url": "https://www.investing.com/news/stock-market-news/former-exec-baglino-sells-tesla-shares-worth-1815-million-sec-filing-shows-3400033",
"image_url": "https://i-invdn-com.investing.com/news/LYNXNPEB6G10B_L.jpg",
"language": "en",
"published_at": "2024-04-26T04:06:10.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "TSLA",
"name": "Tesla, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 25.149883,
"sentiment_score": 0.53805,
"highlights": [
{
"highlight": "(Reuters) - Former <em>Tesla</em> (NASDAQ: ) executive Drew Baglino has sold shares worth around $181.5 million in the world's top EV maker, according to a SEC filing on Thursday.\n\nBaglino, a <em>Tesla</em> veteran who began his career as an engineer in 2006 and was one of four members, along with Elon Musk, on the company's leadership team.",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "Former exec Baglino sells <em>Tesla</em> shares worth $181.5 million, SEC filing shows By Reuters",
"sentiment": 0.4767,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "931d640d-a120-48c7-ba52-044c4dfeda7d",
"title": "India-made chips may soon power iPhones",
"description": "Micron Technology, a global leader in memory and storage, is considering supplying Made-in-India chips from its Gujarat plant to one of its key global clients, Apple, whose vendors assemble iPhones in the country.\n\nMicron is setting up an assembly test marking and packaging (ATMP) plant in Sanand, Gujarat.\n\nCurrently, Apple vendors import chips for manufacturing iPhones. Sources in the know say the aim is to use part of the production to supply to Micron's clients in India directly.",
"keywords": "Business news, business news India, India business news, Indian economy news, Indian financial news",
"snippet": "Micron Technology, a global leader in memory and storage, is considering supplying Made-in-India chips from its Gujarat plant to one of its key global clients, ...",
"url": "https://www.rediff.com/business/report/tech-india-made-chips-may-soon-power-iphones/20240426.htm",
"image_url": "https://im.rediff.com/money/2023/jun/22micron.jpg",
"language": "en",
"published_at": "2024-04-26T04:04:08.000000Z",
"source": "rediff.com",
"relevance_score": null,
"entities": [
{
"symbol": "AAPL",
"name": "Apple Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 15.37598,
"sentiment_score": 0.113333,
"highlights": [
{
"highlight": "Micron Technology, a global leader in memory and storage, is considering supplying Made-in-India chips from its Gujarat plant to one of its key global clients, <em>Apple</em>, whose vendors assemble iPhones in the country.\n\nPhotograph: Stephen Nellis/Reuters\n\nMicron is setting up an assembly test marking and packaging (ATMP) plant in Sanand, Gujarat.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Currently, <em>Apple</em> vendors import chips for manufacturing iPhones. Sources in the know say the aim is to use part of the production to supply to Micron’s clients in India directly.\n\nThe Sanand plant is expected to roll out the first India-made chips by December.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "However, a final deal will depend on <em>Apple</em> <em>Inc</em> agreeing to it.",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Although the chips will be exported initially in the first phase, Micron is planning to supply them directly to its global clients in the next phase to manufacturing or assembly facilities in India and <em>Apple</em> is one of them; Apple’s three vendors assemble iPhones in the country and, in fact,\n\n12 per cent of total iPhone production is assembled in India",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> declined to comment. Micron Technology did not respond to questions either in India or at its headquarters.\n\nThe use of Made in India chips will go a long way in Apple’s drive for value addition here, which is currently pegged at only 10-12 per cent.",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Apart from <em>Apple</em>, Micron’s global clients include Dell, HP, Lenovo, IBM, and Samsung, many of whom have a manufacturing base or vendors in India.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "a575e0b1-2824-46a7-9a95-daa2699eb765",
"title": "IBM Q1: Big Blue Sees Crimson As It Blows Money On HashiCorp",
"description": "International Business Machines may not be sustainable in the face of increasing competition and a potential downturn. See why IBM stock is a Hold.",
"keywords": "",
"snippet": "Anne Czichos\n\nTiming is everything in markets. When we last covered International Business Machines Corporation (NYSE:IBM) we looked at the results and the valu...",
"url": "https://seekingalpha.com/article/4686511-ibm-stock-q1-earnings-big-blue-sees-crimson-as-it-blows-money-on-hashicorp",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1313906739/image_1313906739.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2024-04-26T03:53:26.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "MSFT",
"name": "Microsoft Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 9.478981,
"sentiment_score": -0.7351,
"highlights": [
{
"highlight": "Sure, you can argue that it is cheaper relative to <em>Microsoft</em> <em>Corporation</em> (MSFT) Accenture Plc. (ACN). That only means that you will likely lose a lower percentage. Your odds of outperforming even 10-Year Treasuries from here remains poor.",
"sentiment": -0.7351,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "26ab1e72-3ded-4028-b3db-186267a81698",
"title": "PTC Therapeutics, Inc. (PTCT) Q1 2024 Earnings Call Transcript",
"description": "PTC Therapeutics, Inc. (NASDAQ:NASDAQ:PTCT) Q1 2024 Earnings Conference Call April 25, 2024 4:30 PM ETCompany ParticipantsJane Hanlon - Associate Director...",
"keywords": "",
"snippet": "PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Conference Call April 25, 2024 4:30 PM ET\n\nCompany Participants\n\nJane Hanlon - Associate Director of Inves...",
"url": "https://seekingalpha.com/article/4686527-ptc-therapeutics-inc-ptct-q1-2024-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-04-26T03:52:09.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "PTCT",
"name": "PTC Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 141.6839,
"sentiment_score": 0.164925,
"highlights": [
{
"highlight": "<em>PTC</em> <em>Therapeutics</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>NASDAQ:PTCT</em>) Q1 2024 Earnings Conference Call April 25, 2024 4:30 PM ET\n\nCompany Participants\n\nJane Hanlon - Associate Director of Investor Relations\n\nMatthew Klein - Chief Executive Officer\n\nEric Pauwels - Chief Business Officer\n\nKylie O’Keefe - Chief Commercial Officer\n\nPierre Gravier - Chief Financial Officer\n\nConference Call Participants\n\nKristen",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Jane Hanlon\n\nGood afternoon and thank you for joining us today to discuss <em>PTC</em> <em>Therapeutics</em> first quarter 2024 corporate update and financial results. I'm joined today by our Chief Executive Officer, Dr.",
"sentiment": 0.6597,
"highlighted_in": "main_text"
},
{
"highlight": "<em>PTC</em> <em>Therapeutics</em>, <em>Inc</em>. (PTCT) Q1 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "84efb5cb-d228-4669-a2a2-43f47431c2aa",
"title": "CIDARA Therapeutics ALERT: Bragar Eagel & Squire, P.C. is Investigating Cidara Therapeutics, Inc. on Behalf of Cidara Therapeutics Stockholders and Encourages Investors to Contact the Firm",
"description": "NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating...",
"keywords": "Bragar Eagel & Squire, Cidara Therapeutics, CDTX, securities, class action, stockholder rights, litigate, legal, lawyer, lawsuit, Investigation, share, stock, investor, Class Action",
"snippet": "NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims...",
"url": "https://www.globenewswire.com/news-release/2024/04/26/2870203/0/en/CIDARA-Therapeutics-ALERT-Bragar-Eagel-Squire-P-C-is-Investigating-Cidara-Therapeutics-Inc-on-Behalf-of-Cidara-Therapeutics-Stockholders-and-Encourages-Investors-to-Contact-the-Fir.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/29481954-f2ff-4756-b5a9-d982a6497bd0",
"language": "en",
"published_at": "2024-04-26T01:00:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "CDTX",
"name": "Cidara Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 152.44225,
"sentiment_score": 0.265986,
"highlights": [
{
"highlight": "., a nationally recognized stockholder rights law firm, is investigating potential claims against <em>Cidara</em> <em>Therapeutics</em>, <em>Inc</em>. (“<em>Cidara</em> <em>Therapeutics</em>” or the “Company”) (<em>NASDAQ</em>: <em>CDTX</em>) on behalf of <em>Cidara</em> <em>Therapeutics</em> stockholders.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Our investigation concerns whether <em>Cidara</em> <em>Therapeutics</em> has violated the federal securities laws and/or engaged in other unlawful business practices.\n\n\n\nClick here to participate in the action.\n\nOn April 16, 2024, <em>Cidara</em> <em>Therapeutics</em> filed a current report on Form 8-K with the SEC.",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "In this 8-K, <em>Cidara</em> <em>Therapeutics</em> announced that it’s “previously issued audited consolidated financial statements for the fiscal years ended December 31, 2021 and 2022 included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, and each of the Company’s previously issued unaudited condensed consolidated financial",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Cidara</em> <em>Therapeutics</em> further announced that its management had “concluded that the Company’s disclosure controls and procedures were not effective at the reasonable assurance level and the Company’s internal control over financial reporting was not effective as of the end of each of the periods covered by the restatement.”",
"sentiment": 0.0437,
"highlighted_in": "main_text"
},
{
"highlight": "On this news, the price of <em>Cidara</em> <em>Therapeutics</em> stock fell by $1.89 per share, or 11.46%, to close at $14.60 on April 16, 2024.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "If you purchased or otherwise acquired <em>Cidara</em> <em>Therapeutics</em> shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations",
"sentiment": 0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CIDARA</em> <em>Therapeutics</em> ALERT: Bragar Eagel & Squire, P.C. is Investigating <em>Cidara</em> <em>Therapeutics</em>, <em>Inc</em>. on Behalf of <em>Cidara</em> <em>Therapeutics</em> Stockholders and Encourages Investors to Contact the Firm",
"sentiment": 0.7034,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "07041e2b-94b5-4555-8f30-002fdbf7cb4e",
"title": "Gilead Sciences Inc (GILD) Q1 2024 Earnings: Misses Analyst EPS Estimates Amid Significant Acquisition Charges",
"description": "Total Revenue: Reached $6.7 billion in Q1 2024, a 5% increase year-over-year, exceeding estimates of $6.338 billion.Net Loss: Reported a significant net loss d",
"keywords": "GuruFocus, Article, News, GuruFocus Research, GILD",
"snippet": "Gilead Sciences Inc (GILD, Financial) released its 8-K filing on April 25, 2024, revealing a challenging first quarter with significant financial impacts due to...",
"url": "https://www.gurufocus.com/news/2418577/gilead-sciences-inc-gild-q1-2024-earnings-misses-analyst-eps-estimates-amid-significant-acquisition-charges",
"image_url": "https://static.gurufocus.com/logos/0C000007VR.png?5",
"language": "en",
"published_at": "2024-04-25T21:41:51.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "GIS.DE",
"name": "Gilead Sciences, Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 119.70453,
"sentiment_score": 0.2189,
"highlights": [
{
"highlight": "<em>Gilead</em> <em>Sciences</em> <em>Inc</em> (GILD, Financial) released its 8-K filing on April 25, 2024, revealing a challenging first quarter with significant financial impacts due to acquisition-related expenses.",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Conclusion\n\nWhile <em>Gilead</em> <em>Sciences</em> <em>Inc</em> (GILD, Financial) demonstrates strong revenue growth and strategic expansion through acquisitions, the substantial financial impacts from these activities have posed significant challenges to its earnings performance in the first quarter of 2024.",
"sentiment": 0.8316,
"highlighted_in": "main_text"
},
{
"highlight": "Explore the complete 8-K earnings release (here) from <em>Gilead</em> <em>Sciences</em> <em>Inc</em> for further details.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Gilead</em> <em>Sciences</em> <em>Inc</em> (GILD) Q1 2024 Earnings: Misses Analyst EPS Estimates Amid Significant Acquisition Charges",
"sentiment": -0.296,
"highlighted_in": "title"
}
]
},
{
"symbol": "GILD.MX",
"name": "Gilead Sciences, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 119.64623,
"sentiment_score": 0.2189,
"highlights": [
{
"highlight": "<em>Gilead</em> <em>Sciences</em> <em>Inc</em> (GILD, Financial) released its 8-K filing on April 25, 2024, revealing a challenging first quarter with significant financial impacts due to acquisition-related expenses.",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Conclusion\n\nWhile <em>Gilead</em> <em>Sciences</em> <em>Inc</em> (GILD, Financial) demonstrates strong revenue growth and strategic expansion through acquisitions, the substantial financial impacts from these activities have posed significant challenges to its earnings performance in the first quarter of 2024.",
"sentiment": 0.8316,
"highlighted_in": "main_text"
},
{
"highlight": "Explore the complete 8-K earnings release (here) from <em>Gilead</em> <em>Sciences</em> <em>Inc</em> for further details.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Gilead</em> <em>Sciences</em> <em>Inc</em> (GILD) Q1 2024 Earnings: Misses Analyst EPS Estimates Amid Significant Acquisition Charges",
"sentiment": -0.296,
"highlighted_in": "title"
}
]
},
{
"symbol": "GILD",
"name": "Gilead Sciences, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 119.62751,
"sentiment_score": 0.2189,
"highlights": [
{
"highlight": "<em>Gilead</em> <em>Sciences</em> <em>Inc</em> (GILD, Financial) released its 8-K filing on April 25, 2024, revealing a challenging first quarter with significant financial impacts due to acquisition-related expenses.",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Conclusion\n\nWhile <em>Gilead</em> <em>Sciences</em> <em>Inc</em> (GILD, Financial) demonstrates strong revenue growth and strategic expansion through acquisitions, the substantial financial impacts from these activities have posed significant challenges to its earnings performance in the first quarter of 2024.",
"sentiment": 0.8316,
"highlighted_in": "main_text"
},
{
"highlight": "Explore the complete 8-K earnings release (here) from <em>Gilead</em> <em>Sciences</em> <em>Inc</em> for further details.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Gilead</em> <em>Sciences</em> <em>Inc</em> (GILD) Q1 2024 Earnings: Misses Analyst EPS Estimates Amid Significant Acquisition Charges",
"sentiment": -0.296,
"highlighted_in": "title"
}
]
},
{
"symbol": "GILDD.BA",
"name": "GILEAD SCIENCES",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 105.94603,
"sentiment_score": 0.2189,
"highlights": [
{
"highlight": "<em>Gilead</em> <em>Sciences</em> Inc (GILD, Financial) released its 8-K filing on April 25, 2024, revealing a challenging first quarter with significant financial impacts due to acquisition-related expenses.",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Conclusion\n\nWhile <em>Gilead</em> <em>Sciences</em> Inc (GILD, Financial) demonstrates strong revenue growth and strategic expansion through acquisitions, the substantial financial impacts from these activities have posed significant challenges to its earnings performance in the first quarter of 2024.",
"sentiment": 0.8316,
"highlighted_in": "main_text"
},
{
"highlight": "Explore the complete 8-K earnings release (here) from <em>Gilead</em> <em>Sciences</em> Inc for further details.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Gilead</em> <em>Sciences</em> Inc (GILD) Q1 2024 Earnings: Misses Analyst EPS Estimates Amid Significant Acquisition Charges",
"sentiment": -0.296,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "715e447f-447d-4923-a226-b6bf70eb03d4",
"title": "PTC Therapeutics Q1 2024 Earnings: A Detailed Financial Review",
"description": "Reported Revenue: $210.12 million in Q1 2024, falling short of the estimated $169.70 million.Net Loss: Reported a net loss of $91.58 million, exceeding the est",
"keywords": "GuruFocus, Article, News, GuruFocus Research, PTCT",
"snippet": "On April 25, 2024, PTC Therapeutics Inc (PTCT, Financial) unveiled its financial outcomes for the first quarter of 2024 through its 8-K filing. The company, a p...",
"url": "https://www.gurufocus.com/news/2418570/ptc-therapeutics-q1-2024-earnings-a-detailed-financial-review",
"image_url": "https://static.gurufocus.com/logos/0C0000A4M9.png?5",
"language": "en",
"published_at": "2024-04-25T21:39:19.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PTCT",
"name": "PTC Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 87.34723,
"sentiment_score": 0.331578,
"highlights": [
{
"highlight": "On April 25, 2024, <em>PTC</em> <em>Therapeutics</em> <em>Inc</em> (PTCT, Financial) unveiled its financial outcomes for the first quarter of 2024 through its 8-K filing. The company, a prominent player in the biopharmaceutical sector, focuses on developing small-molecule therapeutics that target RNA biology and post-transcriptional control processes.",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Company Overview\n\n<em>PTC</em> <em>Therapeutics</em> operates in the niche market of rare disorders and oncology, with a strategic focus on diseases like Duchenne muscular dystrophy and aromatic l-Amino Acid Decarboxylase deficiency.",
"sentiment": 0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Performance Highlights\n\nThe first quarter saw <em>PTC</em> <em>Therapeutics</em> generate a total revenue of $210.118 million, a decrease from the previous year's $220.382 million.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>PTC</em> <em>Therapeutics</em>' balance sheet remains robust with cash, cash equivalents, and marketable securities totaling $884.813 million as of March 31, 2024. This financial positioning supports the company's ongoing projects and strategic initiatives.",
"sentiment": 0.7269,
"highlighted_in": "main_text"
},
{
"highlight": "Strategic and Operational Highlights\n\nDuring the quarter, <em>PTC</em> <em>Therapeutics</em> made significant progress in its pipeline development. The company submitted a Marketing Authorization Application (MAA) for sepiapterin and a Biologics License Application (BLA) for Upstaza, marking critical steps towards bringing these therapies to market.",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Future Outlook\n\nLooking ahead, <em>PTC</em> <em>Therapeutics</em> reaffirmed its full-year 2024 financial guidance, reflecting confidence in its operational strategy and pipeline progress. The company remains on track to meet its clinical and regulatory milestones for the year, which is crucial for sustaining growth and enhancing shareholder value.",
"sentiment": 0.8779,
"highlighted_in": "main_text"
},
{
"highlight": "In conclusion, <em>PTC</em> <em>Therapeutics</em>' first quarter of 2024 demonstrates a strategic realignment and optimization of its development efforts.",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "Explore the complete 8-K earnings release (here) from <em>PTC</em> <em>Therapeutics</em> <em>Inc</em> for further details.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>PTC</em> <em>Therapeutics</em> Q1 2024 Earnings: A Detailed Financial Review",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "0add1f02-6e5f-42fe-8f42-0cd64708e3a0",
"title": "Hub Group, Inc. (HUBG) Q1 2024 Earnings Call Transcript",
"description": "Hub Group, Inc. (NASDAQ:NASDAQ:HUBG) Q1 2024 Earnings Conference Call April 25, 2024 5:00 PM ETCompany ParticipantsPhillip Yeager - President, CEO &...",
"keywords": "",
"snippet": "Hub Group, Inc. (NASDAQ:HUBG) Q1 2024 Earnings Conference Call April 25, 2024 5:00 PM ET\n\nCompany Participants\n\nPhillip Yeager - President, CEO & Vice Chairman\n...",
"url": "https://seekingalpha.com/article/4686524-hub-group-inc-hubg-q1-2024-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-04-26T03:37:07.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "HUBG",
"name": "Hub Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 65.671776,
"sentiment_score": 0.1223,
"highlights": [
{
"highlight": "<em>Hub</em> <em>Group</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>NASDAQ:HUBG</em>) Q1 2024 Earnings Conference Call April 25, 2024 5:00 PM ET\n\nCompany Participants\n\nPhillip Yeager - President, CEO & Vice Chairman\n\nBrian Alexander - EVP & COO\n\nKevin Beth - EVP, CFO & Treasurer\n\nConference Call Participants\n\nScott Group - Wolfe Research\n\nJon Chappell - Evercore ISI\n\nBascome Majors - Susquehanna Financial Group\n\nBrian Ossenbeck",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "And Kevin, Brian and I are available as always to answer any questions\n\nOperator\n\nLadies and gentlemen, this concludes today's conference call with <em>Hub</em> <em>Group</em>, <em>Inc</em>. Thank you for joining. You may now disconnect.",
"sentiment": 0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Hub</em> <em>Group</em>, <em>Inc</em>. (HUBG) Q1 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "09b586c2-04e0-42b4-9fa1-84b9033ef3df",
"title": "Hub Group Inc (HUBG) First Quarter 2024 Earnings: Surpasses EPS Estimates Amidst Market Challenges",
"description": "Earnings Per Share (EPS): Reported at $0.44, surpassing the estimated $0.39.Revenue: Totaled $999.5 million for the quarter, falling short of the estimated $10",
"keywords": "GuruFocus, Article, News, GuruFocus Research, HUBG",
"snippet": "On April 25, 2024, Hub Group Inc (HUBG, Financial) disclosed its financial results for the first quarter of 2024, revealing a diluted earnings per share (EPS) o...",
"url": "https://www.gurufocus.com/news/2418599/hub-group-inc-hubg-first-quarter-2024-earnings-surpasses-eps-estimates-amidst-market-challenges",
"image_url": "https://static.gurufocus.com/logos/0C00000BC9.png?5",
"language": "en",
"published_at": "2024-04-25T21:48:50.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "HUBG",
"name": "Hub Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 54.16295,
"sentiment_score": 0.17285,
"highlights": [
{
"highlight": "On April 25, 2024, <em>Hub</em> <em>Group</em> <em>Inc</em> (HUBG, Financial) disclosed its financial results for the first quarter of 2024, revealing a diluted earnings per share (EPS) of $0.44, which notably surpasses the analyst's estimate of $0.39. The company reported a quarterly revenue of $1.0 billion, aligning closely with expectations.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Hub</em> <em>Group</em> <em>Inc</em>\n\nHub Group stands as a prominent player in the transportation sector, primarily known for its rail intermodal service, which constitutes about 60% of its revenue.",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Explore the complete 8-K earnings release (here) from <em>Hub</em> <em>Group</em> <em>Inc</em> for further details.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Hub</em> <em>Group</em> <em>Inc</em> (HUBG) First Quarter 2024 Earnings: Surpasses EPS Estimates Amidst Market Challenges",
"sentiment": 0.0772,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "b4314d8d-18a6-4756-bcd5-eb89d70da2d3",
"title": "The Shyft Group, Inc. (SHYF) Q1 2024 Earnings Call Transcript",
"description": "The Shyft Group, Inc. (NASDAQ:NASDAQ:SHYF) Q1 2024 Earnings Call Transcript April 25, 2024 8:30 AM ETCompany ParticipantsRandy Wilson - Vice President,...",
"keywords": "",
"snippet": "The Shyft Group, Inc. (NASDAQ:SHYF) Q1 2024 Earnings Call Transcript April 25, 2024 8:30 AM ET\n\nCompany Participants\n\nRandy Wilson - Vice President, Investor Re...",
"url": "https://seekingalpha.com/article/4686335-shyft-group-inc-shyf-q1-2024-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-04-25T19:28:13.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "SHYF",
"name": "The Shyft Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 138.7221,
"sentiment_score": 0.553678,
"highlights": [
{
"highlight": "<em>The</em> <em>Shyft</em> <em>Group</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>NASDAQ:SHYF</em>) Q1 2024 Earnings Call Transcript April 25, 2024 8:30 AM ET\n\nCompany Participants\n\nRandy Wilson - Vice President, Investor Relations & Treasury\n\nJohn Dunn - President & Chief Executive Officer\n\nJonathan Douyard - Chief Financial Officer\n\nConference Call Participants\n\nMatt Koranda - Roth MKM\n\nTyler DiMatteo - BTIG\n\nOperator\n\nGood morning",
"sentiment": 0.5719,
"highlighted_in": "main_text"
},
{
"highlight": ", and welcome to <em>The</em> <em>Shyft</em> Group's First Quarter 2024 Conference Call and Webcast.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "And I would now like to introduce Randy Wilson, Vice President of Investor Relations and Treasury for <em>The</em> <em>Shyft</em> Group. Please go ahead.\n\nRandy Wilson\n\nGood morning, and thank you for joining us. Today, you will hear from John Dunn, President and Chief Executive Officer; and Jon Douyard, Chief Financial Officer.",
"sentiment": 0.875,
"highlighted_in": "main_text"
},
{
"highlight": "I would like to welcome everyone to our earnings call, and appreciate your interest in <em>The</em> <em>Shyft</em> Group. Through the first quarter, our team delivered results better than our outlook provided in February.",
"sentiment": 0.9201,
"highlighted_in": "main_text"
},
{
"highlight": "<em>The</em> <em>Shyft</em> team continues to prioritize these efforts to drive long-term performance.\n\nNow let's turn to Slide 5, and I will provide an update around the status of the Blue ARC EV program. As discussed on our last call, we focused our team's efforts on bringing the Class 3 and Class 4 Blue Arc EV walk-in van to market later this year.",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "I want to conclude today's prepared remarks by first extending my appreciation to <em>the</em> <em>Shyft</em> team as we continue our improvement journey. At the start of the call, I highlighted our commitment to enhancing shareholder value and returning Shyft to historic profitability by implementing our operational framework.",
"sentiment": 0.9274,
"highlighted_in": "main_text"
},
{
"highlight": "<em>The</em> <em>Shyft</em> management team looks forward to connecting with the investment community over the coming months. Thank you for your interest in <em>The</em> <em>Shyft</em> Group. And as always, please reach out to us if you have any follow-up questions.\n\nWith that, operator, please disconnect the call.\n\nOperator\n\nThis concludes the call.",
"sentiment": 0.8481,
"highlighted_in": "main_text"
},
{
"highlight": "<em>The</em> <em>Shyft</em> <em>Group</em>, <em>Inc</em>. (SHYF) Q1 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "MLKRI.PA",
"name": "Well SA",
"exchange": null,
"exchange_long": null,
"country": "fr",
"type": "equity",
"industry": "Financial Services",
"match_score": 5.782061,
"sentiment_score": 0.410338,
"highlights": [
{
"highlight": "Key financial highlights include: Our specialty vehicle team continued to perform <em>well</em> with another solid quarter that resulted in high-teens margin.\n\nIn addition, we saw early signs of commercial progress as the FVS team delivered the highest order level in nearly two years, resulting in their first sequential backlog increase since early 2022.",
"sentiment": 0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "Although we remain cautious about the timing of the parcel market recovery, we believe our business is <em>well</em>-positioned to deliver for our customers as it returns. Overall, I want to emphasize that Shyft team members are acting with urgency to drive improved results and return the company to historical profitability over time.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "Adjusted EBITDA for the quarter was $0.9 million versus $12.5 million a year ago, with the decline in profitability driven by the impacts of lower sales volume as <em>well</em> as negative product mix. Adjusted EBITDA margin was 0.9% of sales compared to 7.8% in the first quarter last year.",
"sentiment": -0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "And as John mentioned in his prepared remarks, we really saw strength from a utility perspective as <em>well</em> as in food and beverage in the quarter.\n\nSo if you look at it, just maybe for some historical perspective, if you go back a couple of years, FVS was 75% parcel, 25% other vocations.",
"sentiment": 0.6573,
"highlighted_in": "main_text"
},
{
"highlight": "So some of that may be in the third quarter as <em>well</em>.\n\nMatt Koranda\n\nOkay. All right. That's helpful. Thanks, Jon. And then just on the Blue Arc program, curious if we could maybe shift to that and discuss, when do we expect -- I guess, <em>well</em>, one, do we feel like the battery supplier issue is fully sorted at this point?",
"sentiment": 0.886,
"highlighted_in": "main_text"
},
{
"highlight": "We're <em>well</em>-positioned throughout the country. But we can do more with what we already have. And that's really the first step.\n\nThere's also going to be a need for some additional site locations as we continue our expansion plans.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "We continue to have discussions with the previous battery supplier as <em>well</em>. And that is an option, if needed, and then we're out there on the market, looking at one to two other battery suppliers, just in case there is that need. But as of today, we're really focused on Our Next Energy to be the battery that we go into production with.",
"sentiment": 0.6077,
"highlighted_in": "main_text"
},
{
"highlight": "Has Shyft given this area any thought, especially with the OEMs you already know so <em>well</em>?\n\nJonathan Douyard\n\nYes, I think, Linda, I think what I would say there is we do continue to do that. I mean, we've built -- if you go back to 2023, we built over 1,000 EV either bodies or van upfits.",
"sentiment": 0.4019,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MLWEL.PA",
"name": "Well SA",
"exchange": null,
"exchange_long": null,
"country": "fr",
"type": "equity",
"industry": "N/A",
"match_score": 5.782042,
"sentiment_score": 0.410338,
"highlights": [
{
"highlight": "Key financial highlights include: Our specialty vehicle team continued to perform <em>well</em> with another solid quarter that resulted in high-teens margin.\n\nIn addition, we saw early signs of commercial progress as the FVS team delivered the highest order level in nearly two years, resulting in their first sequential backlog increase since early 2022.",
"sentiment": 0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "Although we remain cautious about the timing of the parcel market recovery, we believe our business is <em>well</em>-positioned to deliver for our customers as it returns. Overall, I want to emphasize that Shyft team members are acting with urgency to drive improved results and return the company to historical profitability over time.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "Adjusted EBITDA for the quarter was $0.9 million versus $12.5 million a year ago, with the decline in profitability driven by the impacts of lower sales volume as <em>well</em> as negative product mix. Adjusted EBITDA margin was 0.9% of sales compared to 7.8% in the first quarter last year.",
"sentiment": -0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "And as John mentioned in his prepared remarks, we really saw strength from a utility perspective as <em>well</em> as in food and beverage in the quarter.\n\nSo if you look at it, just maybe for some historical perspective, if you go back a couple of years, FVS was 75% parcel, 25% other vocations.",
"sentiment": 0.6573,
"highlighted_in": "main_text"
},
{
"highlight": "So some of that may be in the third quarter as <em>well</em>.\n\nMatt Koranda\n\nOkay. All right. That's helpful. Thanks, Jon. And then just on the Blue Arc program, curious if we could maybe shift to that and discuss, when do we expect -- I guess, <em>well</em>, one, do we feel like the battery supplier issue is fully sorted at this point?",
"sentiment": 0.886,
"highlighted_in": "main_text"
},
{
"highlight": "We're <em>well</em>-positioned throughout the country. But we can do more with what we already have. And that's really the first step.\n\nThere's also going to be a need for some additional site locations as we continue our expansion plans.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "We continue to have discussions with the previous battery supplier as <em>well</em>. And that is an option, if needed, and then we're out there on the market, looking at one to two other battery suppliers, just in case there is that need. But as of today, we're really focused on Our Next Energy to be the battery that we go into production with.",
"sentiment": 0.6077,
"highlighted_in": "main_text"
},
{
"highlight": "Has Shyft given this area any thought, especially with the OEMs you already know so <em>well</em>?\n\nJonathan Douyard\n\nYes, I think, Linda, I think what I would say there is we do continue to do that. I mean, we've built -- if you go back to 2023, we built over 1,000 EV either bodies or van upfits.",
"sentiment": 0.4019,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "54db6102-af9d-40a8-a325-2513c19e7494",
"title": "Intel CEO Pat Gelsinger Aims To Regain Lost Ground After Disappointing Results: 'The Road Map Is Healthy' - Intel (NASDAQ:INTC)",
"description": "Gelsinger, during the Q1 earnings call, highlighted the company's upcoming products and their potential to regain market share.",
"keywords": "",
"snippet": "Loading... Loading...\n\nIntel Corporation INTC CEO Pat Gelsinger expressed confidence in the company’s future, despite a disappointing first-quarter performanc...",
"url": "https://www.benzinga.com/news/earnings/24/04/38450677/intel-ceo-pat-gelsinger-aims-to-regain-lost-ground-after-disappointing-results-the-road-map-is-heal",
"image_url": "https://cdn.benzinga.com/files/images/story/2024/04/25/Tel-Aviv--Israel---March-30--2016-Intel-.jpeg?width=1200&height=800&fit=crop",
"language": "en",
"published_at": "2024-04-26T03:32:05.000000Z",
"source": "benzinga.com",
"relevance_score": null,
"entities": [
{
"symbol": "INTC",
"name": "Intel Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 39.357346,
"sentiment_score": 0.15455,
"highlights": [
{
"highlight": "<em>Intel</em> <em>Corporation</em> INTC CEO Pat Gelsinger expressed confidence in the company’s future, despite a disappointing first-quarter performance.\n\nWhat Happened: Gelsinger, during the first quarter earnings call, highlighted the company’s upcoming products and their potential to regain market share.",
"sentiment": 0.7306,
"highlighted_in": "main_text"
},
{
"highlight": "Intel CEO Pat Gelsinger Aims To Regain Lost Ground After Disappointing Results: 'The Road Map Is Healthy' - Intel (<em>NASDAQ:INTC</em>)",
"sentiment": -0.4215,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "9dcba6c2-95fc-4f11-8dd6-5bea001cea62",
"title": "SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Sharecare, Inc. with Losses to Contact the Firm",
"description": "LOS ANGELES, April 25, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sharecare, Inc. for...",
"keywords": "Markets",
"snippet": "LOS ANGELES, April 25, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit aga...",
"url": "https://www.marketscreener.com/quote/stock/SHARECARE-INC-124414772/news/SHAREHOLDER-ACTION-ALERT-The-Schall-Law-Firm-Encourages-Investors-in-Sharecare-Inc-with-Losses-to-46539687/",
"image_url": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
"language": "en",
"published_at": "2024-04-26T03:31:08.000000Z",
"source": "marketscreener.com",
"relevance_score": null,
"entities": [
{
"symbol": "SHCR",
"name": "Sharecare, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 114.523125,
"sentiment_score": -0.09694,
"highlights": [
{
"highlight": "LOS ANGELES, April 25, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against <em>Sharecare</em>, <em>Inc</em>.",
"sentiment": -0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "(\"<em>Sharecare</em>\" or \"the Company\") (<em>NASDAQ</em>: <em>SHCR</em>) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Sharecare</em> failed to maintain appropriate internal controls. Based on this fact, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about <em>Sharecare</em>, investors suffered damages.\n\nJoin the case to recover your losses.",
"sentiment": -0.8834,
"highlighted_in": "main_text"
},
{
"highlight": "CONTACT:\n\nThe Schall Law Firm\n\nBrian Schall, Esq.,\n\nwww.schallfirm.com\n\nOffice: 310-301-3335\n\[email protected]\n\nView original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-action-alert-the-schall-law-firm-encourages-investors-in-<em>sharecare</em>-<em>inc</em>-with-losses-to-contact-the-firm-302128329.html\n\nSOURCE The Schall Law",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in <em>Sharecare</em>, <em>Inc</em>. with Losses to Contact the Firm",
"sentiment": 0.4824,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "b36a43d8-108d-4cd2-b5b4-e2cc6646945c",
"title": "ROSEN, A LEADING NATIONAL FIRM, Encourages Sharecare, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SHCR",
"description": "NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on...",
"keywords": "The Rosen Law Firm PA, Rosen Law Firm, Sharecare, NASDAQ: SHCR, Class Action",
"snippet": "NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of...",
"url": "https://www.globenewswire.com/news-release/2024/04/26/2870195/673/en/ROSEN-A-LEADING-NATIONAL-FIRM-Encourages-Sharecare-Inc-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-First-Filed-by-the-Firm-SHCR.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/745335af-3a3a-4fb5-84c0-fdedc9adf092",
"language": "en",
"published_at": "2024-04-26T00:30:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "SHCR",
"name": "Sharecare, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 109.78157,
"sentiment_score": 0.15944,
"highlights": [
{
"highlight": "NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of <em>Sharecare</em> <em>Inc</em>. (<em>NASDAQ</em>: <em>SHCR</em>) between May 10, 2023 and March 28, 2024, both dates inclusive (the “Class Period”). A class action has already been filed.",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "SO WHAT: If you purchased <em>Sharecare</em> securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.\n\nWHAT TO DO NEXT: To join the <em>Sharecare</em> class action, go to https://rosenlegal.com/submit-form/?",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) <em>Sharecare</em> lacked adequate internal controls; and (2) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or",
"sentiment": -0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "To join the <em>Sharecare</em> class action, go to https://rosenlegal.com/submit-form/?case_id=24143 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.\n\nNo Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, A LEADING NATIONAL FIRM, Encourages <em>Sharecare</em>, <em>Inc</em>. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – <em>SHCR</em>",
"sentiment": 0.8074,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "7a340c9a-822d-42c4-b0b7-68bcaa61f225",
"title": "IRBT LAWSUIT ALERT: Levi & Korsinsky Notifies iRobot Corporation Investors of a Class Action Lawsuit and Upcoming Deadline",
"description": "NEW YORK, NY / ACCESSWIRE / April 25, 2024 / If you suffered a loss on your iRobot Corporation (NASDAQ:IRBT) investment and want to learn about a ...",
"keywords": "",
"snippet": "NEW YORK, NY / ACCESSWIRE / April 25, 2024 / If you suffered a loss on your iRobot Corporation (NASDAQ:IRBT) investment and want to learn about a potential reco...",
"url": "https://markets.businessinsider.com/news/stocks/irbt-lawsuit-alert-levi-korsinsky-notifies-irobot-corporation-investors-of-a-class-action-lawsuit-and-upcoming-deadline-1033291035",
"image_url": "https://www.accesswire.com/img.ashx?id=856962",
"language": "en",
"published_at": "2024-04-26T03:30:00.000000Z",
"source": "markets.businessinsider.com",
"relevance_score": null,
"entities": [
{
"symbol": "IRBT",
"name": "iRobot Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 85.03366,
"sentiment_score": -0.375033,
"highlights": [
{
"highlight": "NEW YORK, NY / ACCESSWIRE / April 25, 2024 / If you suffered a loss on your <em>iRobot</em> <em>Corporation</em> (<em>NASDAQ:IRBT</em>) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:\n\nhttps://zlk.com/pslra-1/<em>irobot</em>-lawsuit-submission-form?prid=77095&wire=1\n\nor contact Joseph E.",
"sentiment": -0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "THE LAWSUIT: A class action securities lawsuit was filed against <em>iRobot</em> <em>Corporation</em> that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between August 5, 2022 and January 26, 2024.",
"sentiment": -0.8415,
"highlighted_in": "main_text"
},
{
"highlight": "CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) the August 2022 merger of the Company and Amazon, would place Amazon in a sufficiently dominant position in the market for robot vacuum cleaners that U.S. and European antitrust regulators were unlikely to approve the merger; (ii) <em>iRobot</em> had conducted",
"sentiment": 0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "inadequate due diligence into the merger and/or ignored significant risks weighing against the likelihood of regulatory approval; (iii) as a result of all the foregoing, <em>iRobot</em> overstated the likelihood for successfully completing the merger; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant",
"sentiment": -0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "If you suffered a loss in <em>iRobot</em> stock during the relevant time frame - even if you still hold your shares - go to https://zlk.com/pslra-1/<em>irobot</em>-lawsuit-submission-form?prid=77095&wire=1 to learn about your rights to seek a recovery. There is no cost or obligation to participate.",
"sentiment": -0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "IRBT LAWSUIT ALERT: Levi & Korsinsky Notifies <em>iRobot</em> <em>Corporation</em> Investors of a Class Action Lawsuit and Upcoming Deadline",
"sentiment": -0.1531,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "b6108a32-9fe2-42ee-b080-7deb0fb55ec4",
"title": "Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 7, 2024 in iRobot Lawsuit - IRBT",
"description": "NEW YORK, NY / ACCESSWIRE / April 25, 2024 / If you suffered a loss on your iRobot Corporation (NASDAQ:IRBT) investment and want to learn about a ...",
"keywords": "",
"snippet": "NEW YORK, NY / ACCESSWIRE / April 25, 2024 / If you suffered a loss on your iRobot Corporation (NASDAQ:IRBT) investment and want to learn about a potential reco...",
"url": "https://markets.businessinsider.com/news/stocks/levi-korsinsky-reminds-shareholders-of-a-lead-plaintiff-deadline-of-may-7-2024-in-irobot-lawsuit---irbt-1033291030",
"image_url": "https://www.accesswire.com/img.ashx?id=856957",
"language": "en",
"published_at": "2024-04-26T03:30:00.000000Z",
"source": "markets.businessinsider.com",
"relevance_score": null,
"entities": [
{
"symbol": "IRBT",
"name": "iRobot Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 59.161144,
"sentiment_score": -0.387233,
"highlights": [
{
"highlight": "NEW YORK, NY / ACCESSWIRE / April 25, 2024 / If you suffered a loss on your <em>iRobot</em> <em>Corporation</em> (<em>NASDAQ:IRBT</em>) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:\n\nhttps://zlk.com/pslra-1/<em>irobot</em>-lawsuit-submission-form?prid=77090&wire=1\n\nor contact Joseph E.",
"sentiment": -0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "THE LAWSUIT: A class action securities lawsuit was filed against <em>iRobot</em> <em>Corporation</em> that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between August 5, 2022 and January 26, 2024.",
"sentiment": -0.8415,
"highlighted_in": "main_text"
},
{
"highlight": "CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) the August 2022 merger of the Company and Amazon, would place Amazon in a sufficiently dominant position in the market for robot vacuum cleaners that U.S. and European antitrust regulators were unlikely to approve the merger; (ii) <em>iRobot</em> had conducted",
"sentiment": 0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "inadequate due diligence into the merger and/or ignored significant risks weighing against the likelihood of regulatory approval; (iii) as a result of all the foregoing, <em>iRobot</em> overstated the likelihood for successfully completing the merger; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant",
"sentiment": -0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "If you suffered a loss in <em>iRobot</em> stock during the relevant time frame - even if you still hold your shares - go to https://zlk.com/pslra-1/<em>irobot</em>-lawsuit-submission-form?prid=77090&wire=1 to learn about your rights to seek a recovery. There is no cost or obligation to participate.",
"sentiment": -0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 7, 2024 in <em>iRobot</em> Lawsuit - IRBT",
"sentiment": -0.2263,
"highlighted_in": "title"
}
]
},
{
"symbol": "0R38.L",
"name": "iRobot Corporation",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 46.15245,
"sentiment_score": -0.387233,
"highlights": [
{
"highlight": "NEW YORK, NY / ACCESSWIRE / April 25, 2024 / If you suffered a loss on your <em>iRobot</em> <em>Corporation</em> (NASDAQ:IRBT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:\n\nhttps://zlk.com/pslra-1/<em>irobot</em>-lawsuit-submission-form?prid=77090&wire=1\n\nor contact Joseph E.",
"sentiment": -0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "THE LAWSUIT: A class action securities lawsuit was filed against <em>iRobot</em> <em>Corporation</em> that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between August 5, 2022 and January 26, 2024.",
"sentiment": -0.8415,
"highlighted_in": "main_text"
},
{
"highlight": "CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) the August 2022 merger of the Company and Amazon, would place Amazon in a sufficiently dominant position in the market for robot vacuum cleaners that U.S. and European antitrust regulators were unlikely to approve the merger; (ii) <em>iRobot</em> had conducted",
"sentiment": 0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "inadequate due diligence into the merger and/or ignored significant risks weighing against the likelihood of regulatory approval; (iii) as a result of all the foregoing, <em>iRobot</em> overstated the likelihood for successfully completing the merger; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant",
"sentiment": -0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "If you suffered a loss in <em>iRobot</em> stock during the relevant time frame - even if you still hold your shares - go to https://zlk.com/pslra-1/<em>irobot</em>-lawsuit-submission-form?prid=77090&wire=1 to learn about your rights to seek a recovery. There is no cost or obligation to participate.",
"sentiment": -0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 7, 2024 in <em>iRobot</em> Lawsuit - IRBT",
"sentiment": -0.2263,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "b2c50430-2a1a-4ec4-b4c1-f9162522e7a2",
"title": "ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Shoals Technologies Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SHLS",
"description": "NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Shoals...",
"keywords": "The Rosen Law Firm PA, Rosen Law Firm, Shoals Technologies Group, Inc, NASDAQ: SHLS, Class Action",
"snippet": "NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Shoals Technologies ...",
"url": "https://www.globenewswire.com/news-release/2024/04/25/2870159/673/en/ROSEN-TOP-RANKED-INVESTOR-COUNSEL-Encourages-Shoals-Technologies-Group-Inc-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-SHLS.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/745335af-3a3a-4fb5-84c0-fdedc9adf092",
"language": "en",
"published_at": "2024-04-25T21:37:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "SHLS",
"name": "Shoals Technologies Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 127.2659,
"sentiment_score": 0.53615,
"highlights": [
{
"highlight": "NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of <em>Shoals</em> <em>Technologies</em> <em>Group</em>, <em>Inc</em>. (<em>NASDAQ</em>: <em>SHLS</em>) between May 17, 2022 and November 7, 2023, both dates inclusive (the “Class Period”), of the important May 21, 2024 lead plaintiff deadline.",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages <em>Shoals</em> <em>Technologies</em> <em>Group</em>, <em>Inc</em>. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SHLS",
"sentiment": 0.87,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "f8191272-5892-4de5-8a22-221ea2ba2730",
"title": "Shareholders that lost money on Perion Network Ltd.(PERI) should contact Levi & Korsinsky about pending Class Action - PERI",
"description": "NEW YORK, NY / ACCESSWIRE / April 25, 2024 / If you suffered a loss on your Perion Network Ltd. (NASDAQ:PERI) investment and want to learn about a...",
"keywords": "",
"snippet": "NEW YORK, NY / ACCESSWIRE / April 25, 2024 / If you suffered a loss on your Perion Network Ltd. (NASDAQ:PERI) investment and want to learn about a potential rec...",
"url": "https://markets.businessinsider.com/news/stocks/shareholders-that-lost-money-on-perion-network-ltd-peri-should-contact-levi-korsinsky-about-pending-class-action---peri-1033291031",
"image_url": "https://www.accesswire.com/img.ashx?id=856958",
"language": "en",
"published_at": "2024-04-26T03:30:00.000000Z",
"source": "markets.businessinsider.com",
"relevance_score": null,
"entities": [
{
"symbol": "PERI",
"name": "Perion Network Ltd.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 145.8707,
"sentiment_score": -0.5395,
"highlights": [
{
"highlight": "NEW YORK, NY / ACCESSWIRE / April 25, 2024 / If you suffered a loss on your <em>Perion</em> <em>Network</em> <em>Ltd</em>. (<em>NASDAQ:PERI</em>) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:\n\nhttps://zlk.com/pslra-1/perion-network-lawsuit-submission-form?prid=77091&wire=1\n\nor contact Joseph E.",
"sentiment": -0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "THE LAWSUIT: A class action securities lawsuit was filed against <em>Perion</em> <em>Network</em> <em>Ltd</em>. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between February 9, 2021 and April 5, 2024.",
"sentiment": -0.8415,
"highlighted_in": "main_text"
},
{
"highlight": "Shareholders that lost money on <em>Perion</em> <em>Network</em> <em>Ltd</em>.(PERI) should contact Levi & Korsinsky about pending Class Action - PERI",
"sentiment": -0.3182,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "0cb546d1-1b61-45f9-9382-9befa4117618",
"title": "Accolade, Inc. (ACCD) Q4 2024 Earnings Call Transcript",
"description": "Accolade, Inc. (NASDAQ:NASDAQ:ACCD) Q4 2024 Earnings Conference Call April 25, 2024 4:30 PM ETCompany ParticipantsTodd Friedman - Senior Vice President of...",
"keywords": "",
"snippet": "Accolade, Inc. (NASDAQ:ACCD) Q4 2024 Earnings Conference Call April 25, 2024 4:30 PM ET\n\nCompany Participants\n\nTodd Friedman - Senior Vice President of Investor...",
"url": "https://seekingalpha.com/article/4686521-accolade-inc-accd-q4-2024-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-04-26T03:29:07.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "ACCD",
"name": "Accolade, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 101.32539,
"sentiment_score": 0.310973,
"highlights": [
{
"highlight": "<em>Accolade</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>NASDAQ:ACCD</em>) Q4 2024 Earnings Conference Call April 25, 2024 4:30 PM ET\n\nCompany Participants\n\nTodd Friedman - Senior Vice President of Investor Relations\n\nRajeev Singh - Chief Executive Officer\n\nSteve Barnes - Chief Financial Officer\n\nConference Call Participants\n\nJailendra Singh - Trust Securities\n\nStephanie Davis - Barclays\n\nRyan Daniels - William",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "Such forward-looking statements are subject to risks and uncertainties and other factors that could cause the actual results for <em>Accolade</em> to differ materially from those expressed or implied on the call.",
"sentiment": -0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "Just this past quarter, Blue Shield of California published the results from the first full year offering a virtual first plan design called Virtual Blue powered by <em>Accolade</em>. The results were outstanding. Here are some highlights.",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "In addition, recently, as some of you noted, Blue Cross Blue Shield of Arkansas launched an employer offering powered by our navigation platform where customers have the option to also add <em>Accolade</em> care or second opinion capabilities.",
"sentiment": 0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "Notably, approximately 80% of the new <em>Accolade</em> customers that launced on January 1 of this year deployed <em>Accolade</em> care. PlushCare and other acquisitions have flourished since being brought under the <em>Accolade</em> umbrella both individually and as critical components of our B2B offerings.\n\nAs I turn the call over to Steve, a closing thought.",
"sentiment": 0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "Over the next few years, this customer grew modestly through head count and TPE adoption and then in fiscal '22, the customer added EMO and in fiscal '23, the customer added <em>Accolade</em> Care and several more TPE solutions.",
"sentiment": 0.6344,
"highlighted_in": "main_text"
},
{
"highlight": "We saw a quite consistent reperformance by <em>Accolade</em> as compared to prior years even with the elevation of health care costs that we saw certainly in calendar year '23 heading here into '24.",
"sentiment": 0.6808,
"highlighted_in": "main_text"
},
{
"highlight": "The platform connected revenues are an incredibly important part of what we do at <em>Accolade</em>. The entire business, candidly, is focused around this.",
"sentiment": 0.5667,
"highlighted_in": "main_text"
},
{
"highlight": "Steve Barnes\n\nI would just add, Dave, to that if you think back to Capital Markets Day last year, I think [indiscernible] Virta remark that when <em>Accolade</em> is present, we're seeing sometimes 2x utilization there.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Accolade</em>, <em>Inc</em>. (ACCD) Q4 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "NASDAQ",
"total_documents": 2054,
"sentiment_avg": 0.24428049293134238
}
]
}
Other details
Country
- us
- 5,275